Supriya Lifescience Limited (SUPRIYA) — Cash Flow Quality Index
Supriya Lifescience Limited (SUPRIYA) has a Cash Flow Quality Index of 0.65x as of September 2025. Operating cash flow of Rs555.65 Million is below net income of Rs852.17 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Supriya Lifescience Limited total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Supriya Lifescience Limited Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Supriya Lifescience Limited across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SUPRIYA tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Supriya Lifescience Limited (2018–2025)
Year-by-year earnings quality comparison for Supriya Lifescience Limited. For live market cap and the full company financial profile, see Supriya Lifescience Limited (SUPRIYA) total market value.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.92x | Rs1.73 Billion | Rs1.88 Billion | ▼ -3.5% |
| 2024 | 0.95x | Rs1.13 Billion | Rs1.19 Billion | ▲ +77.5% |
| 2023 | 0.54x | Rs661.87 Million | Rs1.23 Billion | ▲ +127.6% |
| 2022 | 0.24x | Rs488.01 Million | Rs2.07 Billion | ▼ -50.7% |
| 2021 | 0.48x | Rs799.30 Million | Rs1.67 Billion | ▼ -60.4% |
| 2020 | 1.21x | Rs1.16 Billion | Rs962.27 Million | ▲ +41.5% |
| 2019 | 0.85x | Rs486.72 Million | Rs571.04 Million | ▼ -57.4% |
| 2018 | 2.00x | Rs174.52 Million | Rs87.28 Million | — |